Sequent launches U.S. clinical trial of brain aneurysm device

California's Sequent Medical begins enrolling patients in an IDE clinical trial of its Web aneurysm embolization system.

Medtech company Sequent Medical enrolled the 1st 4 patients in a new U.S. clinical trial aimed at winning FDA approval for its Web aneurysm protection implant.

The Web implant is made of a Nitinol mesh that is delivered in a "stent-like" manner and deployed into the pouch formed by an aneurysm in order to prevent blood from flowing in. The device already has approve in the European Union.

Sequent Medical

News Well, Clinical Trials, Investigational Device Exemption (IDE), Implants, Vascular

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1B0EGvZ